Quarterly Report · 10-Q
Recursion Pharmaceuticals, Inc.
RXRXNASDAQEQUITYCurrent
Quarterly Report
Filed Aug 5, 2026Accepted Aug 5, 2026, 6:32 AM EDTCIK 1601830Accession 0001601830-26-000098
Company context
Current securities
Registered securities in this filing
RECURSION PHARMACEUTICALS, INC. · 10-Q · Filed 2026-08-05
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Class A Common Stock, par value $0.00001
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Filing context
Context: c-1
Dimensions: Not supplied
Accession 000160183026000098 · 1 registered-security cover member
Read the exact SEC filing ↗As-filed source
Primary evidence